The European Commission has given approval to a high-dose regimen of Spinraza (nusinersen) for people with 5q spinal muscular ...

A higher daily dose of upadacitinib (Rinvoq) was associated with less severe disease and longer clinical remission for ulcerative colitis patients who responded to upadacitinib induction at 8 weeks, a ...

Ultomiris (ravulizumab-cwvz) is a brand-name drug prescribed for certain autoimmune conditions. Ultomiris is given as an intravenous (IV) infusion by a healthcare professional. The drug’s dosing ...

Biogen Inc. announced that the FDA has accepted and the EMA has validated its supplemental New Drug Application for a higher dose regimen of nusinersen, intended for treating spinal muscular atrophy ...

The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...

SCOTTSDALE, AZ — In patients with Graves disease, prescribing a lower maintenance dose of methimazole (MMI) before discontinuing the drug is associated with significantly higher rates of remission, ...